MindBio Targets Global Digital Health Diagnostics Market with World First AI Powered Speech Analytics Technology

(TheNewswire)

Vancouver, British Columbia –TheNewswire - January 27, 2026 –MindBio Therapeutics Corp.(CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), (the“Company” or “MindBio”), abiotechnology company that conducts clinical health research and hasdeveloped a world first AI prediction tool for drug and alcoholintoxication detection by a simple analysis of the voice, is pleasedto announce the Company is targeting the global digital healthdiagnostics market with a first mover advantage in using speech as adiagnostic tool in drug and alcohol intoxication detection.

The voice is a powerful biomarker that can be used toassess and predict internal health and disease states.  The Companyuses sophisticated machine learning models, developed during years ofclinical trials, to analyse voice data and make predictions that areclinically meaningful and useful in a variety of consumer andenterprise situations.

The Company has developed and commercialised atechnology, activated by a simple analysis of the voice and powered byAI to predict drug and alcohol intoxication.  The Company has amassedlarge amounts of data from drug and alcohol clinical trials and hasdeveloped proprietary algorithms as the basis for its predictiontechnologies with remarkable accuracy for the detection of alcohol andhallucinogenic drugs.

The Company is currently showcasing its technologythroughout the USA.  The Company’s core technology can reliablypredict intoxication with hallucinogens and alcohol by analysingvoice.  The Company plans to expand its algorithms to be able todetect other prohibited drugs that are difficult to detectparticularly at scale and volume and require specialised equipment,with MindBio’s solution provided by a simple analysis of the voice.

The voice analytics solution being developed by MindBiois a revolutionary innovation for intoxication detection in workplaceenvironments, particularly where drug and alcohol testing is mandatedby regulators, such as the mining industry, aviation and constructionand where high volume testing at scale for a variety of drugs andalcohol presents major challenges for management, is time consumingand expensive.

In a world first, MindBio has developed an AI modelthat uses over 50 million data points to predict alcohol intoxicationwith remarkable accuracy, just by using the human voice.  Thetechnology goes further to estimate actual blood alcohol concentrationlevels.

The Company is developing an enterprise version and newplatform level technology for health prediction using the human voiceand is expanding its drug and alcohol intoxication technology for usein workplace environments, call centres, mental health and lawenforcement and the Company hopes to make announcements about theprogress of the new technology, new products and markets and potentialcommercial applications, shortly.

The Company’s CEO Justin Hanka said, “The digitalhealth diagnostics market represents a significant opportunity forMindBio to leverage its diagnostics technology with a first moveradvantage in speech analytics for drug and alcohol intoxicationdetection”.

For further information, please contact:

Justin Hanka, Chief ExecutiveOfficer

61 433140886

justin@mindbiotherapeutics.com

www.mindbiotherapeutics.com

About MindBio Therapeutics

MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6;OTCQB: MBQIF) is a biotechnology company headquartered in Vancouver,British Columbia, that for several years has been conducting drug andalcohol research and has created health prediction technologies usingAI and machine learning.  The Company has expertise in using speechanalytics as a prediction tool for drug and alcohol intoxication andhas created a world first voice and AI powered prediction model fordrug and alcohol intoxication for use in consumer and enterprisesituations.  The Company is developing a comprehensive enterpriseplatform using voice and powered by AI for use in detecting drug andalcohol intoxication in workplaces, law enforcement, mental health andtelehealth.

Cautionary Note ConcerningForward-Looking Statements:

The press release contains "forward-lookingstatements" within the meaning of applicable securities laws.Forward-looking statements can be identified by words such as:"anticipate," "intend," "plan,""budget," "believe," "project,""estimate," "expect," "scheduled,""forecast," "strategy," "future,""likely," "may," "to be,""could," "would," "should,""will" and similar references to future periods or thenegative or comparable terminology, as well as terms usually used inthe future and conditional. Forward-looking statements are based onassumptions as of the date they are provided. However, there can be noassurance that such assumptions will reflect the actual outcome ofsuch items or factors.

Additionally, there are known and unknown risk factorsthat could cause the Company's actual results and financialconditions to differ materially from those indicated in theforward-looking statements. Therefore, you should not rely on any ofthese forward-looking statements. Important risk factors that couldcause actual results and financial conditions to differ materiallyfrom those indicated in the forward-looking statements, include amongothers: general economic, market and business conditions in Canada andAustralia; market volatility; unforeseen delays in timelines for anyof the transactions or events described in this press release.  Allforward-looking information is qualified in its entirety by thiscautionary statement.

The Company disclaims any obligation to revise orupdate any such forward-looking statement or to publicly announce theresult of any revisions to any of the forward-looking informationcontained herein to reflect future results, events or developments,except as required by law.

Neither the Canadian Securities Exchange nor itsRegulation Service Provider (as that term is defined in the policiesof the Canadian Securities Exchange) accepts responsibility for theadequacy or accuracy of this release.

Copyright (c) 2026 TheNewswire - All rights reserved.